Short Course of Aerosol Pentamidine as Treatment of Pneumocystis carinii Pneumonia in AIDS

References

• Centers for disease control. January 1–5., 1989, AIDS Weekly Surveillance Report 30
   Google Scholar
• Medina I, Mills J, Leoung G, Hopewell P C, Belle L, Modin G, Benowitz N, Wofsy C B. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim‐sulfamethoxazole versus trimethoprim‐dapsone. N Engl J Med 1990; 323: 776–782
   PubMed Web of Science ®Google Scholar
• Wharton J M, Coleman D L, Wofsy C B, Luce J M, Blumenfeld W, Hadley W K, Ingram‐Drake L, Volberding P A, Hopewell P C. Trimethoprim‐sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med 1986; 105: 37–44
   PubMed Web of Science ®Google Scholar
• Allegra C J, Chabner B A, Tuazon C U, Ogata‐Arakaki D, Baird B, Drake J C, Simmons J T, Lack E E, Shelhamer J H, Balis F, Walker R, Kovacs J A, Lane H C, Masur H. Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immonodeficiency syndrome. N Engl J Med 1987; 317: 978–985
   PubMed Web of Science ®Google Scholar
• McLees B D, Barlow J LR, Kuzma J, Baringtang D C, Schechter P J, Sjoerdsma A. Studies on successful eflornithine treatment of Pneumocystis carinii pneumonia (PCP) in AIDS patients failing conventional therapy. Abstract TH 42 Third Int Conf on AIDS, Washington, DC, June, 1–51987, 155
   Google Scholar
• Toma E, Poisson M, Vega C, Phaneuf D, Morisset R. Clindamycin with primaquine for Pneumocystis carinii pneumonia in AIDS. Abstract 1119 The 28th Interscience Conference on Antimicrobial Agents and Chemotherapy, Los Angeles, Calif., October, 23–261988. American Society for Microbiology, Washington, DC
   Google Scholar
• Montgomery B. Pneumocystis carinii in patients with the acquired immunodeficiency syndrome: Pathophysiology, therapy and prevention. Semin Respir Infect 1989; 4: 102–110
   PubMedGoogle Scholar
• Sattler F R, Cowan R, Nielsen D M, Ruskin J. Trimethoprim‐sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, non‐crossover study. Ann Intern Med 1988; 109: 280–287
   PubMed Web of Science ®Google Scholar
• Dahlbäck M, Nerbrink O, Arborelius M, Hansson H C. Output characteristics from three medical nebulizers. J Aerosol Sci 1986; 17: 563–564
   Web of Science ®Google Scholar
• Conte J E, Chernoff D, Feigal D W, Joseph P, McDonald C, Golden J A. Intravenous or inhaled pentamidine for treating Pneumocystis carinii penumonia in AIDS. Ann Intern Med 1990; 113: 203–209
   PubMed Web of Science ®Google Scholar
• Soo Hoo G W, Mohsenifar Z, Meyer R D. Inhaled or intravenous pentamidine therapy for Pneumocystis carinii pneumonia in AIDS. Ann Intern Med 1990; 113: 195–202
   PubMedGoogle Scholar
• Montgomery A B, Debs R J, Luce J M, Corkery K J, Turner J, Brunette E N, Lin E T, Hopewell P C. Aerosolized pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Lancet 1987; 2: 480–482
   PubMed Web of Science ®Google Scholar
• Donnelly H, Bernard E M, Rothkotter H, Gold J WM, Amstrong D. Distribution of pentamidine in patients with AIDS. J Infect Dis 1988; 157: 985–989
   PubMedGoogle Scholar
• DeLorenzo L J, Maguire G P, Wormser G P, Davidian M M, Stone D J. Persistence of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Chest 1985; 88: 79–83
   PubMedGoogle Scholar
• Shelhamer J H, Ognibene F P, Macher A M, Tuazon C, Steiss R, Longo D, Kovacs J A, Parker M M, Natanson C, Lane H C, Fauci A S, Parrillo J E, Masur H. Persistence of Pneumocystis carinii in lung tissue of acquired immunodeficiency syndrome patients treated for Pneumocystis pneumonia. Am Rev Respir Dis 1984; 130: 1161–1165
   PubMed Web of Science ®Google Scholar
• Waskin H, Stehr‐Green J K, Helmick C G, Sattler F R. Risk factors for hypoglycemia associated with pentamidine therapy for Pneumocystis pneumonia. JAMA 1988; 260: 345–347
   PubMedGoogle Scholar
• Montaner J SG, Lawson L M, Levitt N, Belzberg A, Schechter M T, Ruedy J. Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1990; 113: 14–20
   PubMed Web of Science ®Google Scholar
• Bozzette S A, Sattler F R, Chiu J, Wu A W, Gluckstein D, Kemper C, Bartok A, Niosi J, Abramson I, Coffman J, Hughlett C, Loya R, Cassens B, Akil B, Meng T Z, Boylen C T, Nielsen D, Richman D D, Tilles J G, Leedom J, McCutchan J A. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 1990; 323: 1451–1457
   PubMed Web of Science ®Google Scholar
• Gagnon S, Boota A M, Fischl M A, Baier H, Kirksey O W, La Voie L. Corticosteroids as adjunctive therapy for severe Pneumocystis pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 1990; 323: 1444–1450
   PubMed Web of Science ®Google Scholar
• The National Institutes of Health‐University of California expert panel for corticosteroids as adjunctive therapy for Pneumocystis pneumonia. Consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis pneumonia. N Engl J Med 1990; 323: 1500–1504
   PubMed Web of Science ®Google Scholar